{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T15:01:25Z","timestamp":1781881285454,"version":"3.54.5"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2015\/17\/D\/NZ7\/00814"],"award-info":[{"award-number":["2015\/17\/D\/NZ7\/00814"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023181","name":"Agencja Bada\u0144 Medycznych","doi-asserted-by":"publisher","award":["2023\/ABM\/02\/00012"],"award-info":[{"award-number":["2023\/ABM\/02\/00012"]}],"id":[{"id":"10.13039\/501100023181","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.biopha.2026.119105","type":"journal-article","created":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T08:20:27Z","timestamp":1771662027000},"page":"119105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Oncostatin M-induced ABCC2 suppression sensitizes hepatocellular carcinoma cells to chemotherapeutics"],"prefix":"10.1016","volume":"196","author":[{"given":"Maciej","family":"Przywarty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u0142a\u017cej","family":"Rychlik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Wieczorek-B\u0142au\u017c","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"B\u0142au\u017c","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2026.119105_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drup.2016.03.001","article-title":"ABC transporters as mediators of drug resistance and contributors to cancer cell biology","volume":"26","author":"Fletcher","year":"2016","journal-title":"Drug Resist. Updat"},{"issue":"25","key":"10.1016\/j.biopha.2026.119105_bib2","doi-asserted-by":"crossref","first-page":"15091","DOI":"10.1074\/jbc.271.25.15091","article-title":"cDNA cloning of the hepatocyte canalicular isoform of the multidrug resistance protein, cMrp, reveals a novel conjugate export pump deficient in hyperbilirubinemic mutant rats","volume":"271","author":"Buchler","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2026.119105_bib3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0065-2571(95)00011-9","article-title":"The function of the multidrug resistance proteins (MRP and cMRP) in drug conjugate transport and hepatobiliary excretion","volume":"36","author":"Keppler","year":"1996","journal-title":"Adv. Enzym. Regul."},{"issue":"2","key":"10.1016\/j.biopha.2026.119105_bib4","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0304-4157(95)00006-D","article-title":"Hepatobiliary secretion of organic compounds; molecular mechanisms of membrane transport","volume":"1241","author":"Oude Elferink","year":"1995","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.biopha.2026.119105_bib5","doi-asserted-by":"crossref","first-page":"19782","DOI":"10.1038\/s41598-019-56059-w","article-title":"Protein expression of ABCC2 and SLC22A3 associates with prognosis of pancreatic adenocarcinoma","volume":"9","author":"Cervenkova","year":"2019","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.biopha.2026.119105_bib6","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1124\/dmd.108.024836","article-title":"Correlation between apical localization of Abcc2\/Mrp2 and phosphorylation status of ezrin in rat intestine","volume":"37","author":"Nakano","year":"2009","journal-title":"Drug Metab. Dispos."},{"issue":"7","key":"10.1016\/j.biopha.2026.119105_bib7","first-page":"2847","article-title":"Molecular cloning, sequence analysis, and functional expression of a novel growth regulator, Oncostatin M","volume":"9","author":"Malik","year":"1989","journal-title":"Mol. Cell Biol."},{"issue":"8","key":"10.1016\/j.biopha.2026.119105_bib8","doi-asserted-by":"crossref","first-page":"4282","DOI":"10.1016\/S0021-9258(18)83737-1","article-title":"Identification and characterization of cellular receptors for the growth regulator, Oncostatin M","volume":"264","author":"Linsley","year":"1989","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2026.119105_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116861","article-title":"Oncostatin M reverses ABCG2-mediated mitoxantrone resistance","volume":"176","author":"Blauz","year":"2024","journal-title":"Biomed. Pharm."},{"issue":"12","key":"10.1016\/j.biopha.2026.119105_bib10","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1517\/17425250903304056","article-title":"Regulation of human hepatic drug transporter expression by pro-inflammatory cytokines","volume":"5","author":"Fardel","year":"2009","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119105_bib11","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF00249595","article-title":"Neutral Red (Nr) Assay for Cell Viability and Xenobiotic-Induced Cytotoxicity in Primary Cultures of Human and Rat Hepatocytes","volume":"6","author":"Zhang","year":"1990","journal-title":"Cell Biol. Toxicol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119105_bib12","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/0003-2697(87)90021-2","article-title":"Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction","volume":"162","author":"Chomczynski","year":"1987","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.biopha.2026.119105_bib13","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.vascn.2016.11.001","article-title":"Drug-selected cell line panels for evaluation of the pharmacokinetic consequences of multidrug resistance proteins","volume":"84","author":"Blauz","year":"2017","journal-title":"J. Pharm. Toxicol. Methods"},{"issue":"3","key":"10.1016\/j.biopha.2026.119105_bib14","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.bcp.2015.03.005","article-title":"MK571 inhibits phase-2 conjugation of flavonols by Caco-2\/TC7 cells, but does not specifically inhibit their apical efflux","volume":"95","author":"Barrington","year":"2015","journal-title":"Biochem. Pharmacol."},{"issue":"5","key":"10.1016\/j.biopha.2026.119105_bib15","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.clpt.2006.08.012","article-title":"High-dose methotrexate in pediatric acute lymphoblastic leukemia:: Impact of polymorphisms on plasma concentrations","volume":"80","author":"Rau","year":"2006","journal-title":"Clin. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.biopha.2026.119105_bib16","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1158\/1078-0432.CCR-09-1321","article-title":"P-glycoprotein (P-gp\/Abcb1), Abcc2, and Abcc3 determine the pharmacokinetics of etoposide","volume":"16","author":"Lagas","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2026.119105_bib17","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.2147\/OTT.S207613","article-title":"In vitro transport ability of (G1249A) polymorphic variant towards anticancer drugs","volume":"13","author":"Lian","year":"2020","journal-title":"Oncotargets Ther."},{"issue":"12","key":"10.1016\/j.biopha.2026.119105_bib18","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/j.bcp.2012.09.029","article-title":"ABCC2 is involved in the hepatocyte perinuclear barrier for small organic compounds","volume":"84","author":"Rosales","year":"2012","journal-title":"Biochem. Pharmacol."},{"issue":"16","key":"10.1016\/j.biopha.2026.119105_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25168797","article-title":"Precision medicine in childhood cancer: the influence of genetic polymorphisms on vincristine-induced peripheral neuropathy","volume":"25","author":"Marangoni-Iglecias","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"15","key":"10.1016\/j.biopha.2026.119105_bib20","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.4155\/fmc.15.131","article-title":"Modulators of the human ABCC2: hope from natural sources?","volume":"7","author":"Baiceanu","year":"2015","journal-title":"Future Med. Chem."},{"issue":"40","key":"10.1016\/j.biopha.2026.119105_bib21","doi-asserted-by":"crossref","first-page":"7126","DOI":"10.2174\/13816128113199990493","article-title":"Mechanisms of drug resistance in cancer chemotherapy: coordinated role and regulation of efflux transporters and metabolizing enzymes","volume":"19","author":"Vadlapatla","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.biopha.2026.119105_bib22","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1159\/000086183","article-title":"Mechanisms of drug resistance in cancer chemotherapy","volume":"14","author":"Luqmani","year":"2005","journal-title":"Med. Princ. Pract."},{"issue":"12","key":"10.1016\/j.biopha.2026.119105_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12121193","article-title":"Mechanisms of resistance to chemotherapy in breast cancer and possible targets in drug delivery systems","volume":"12","author":"Lainetti","year":"2020","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.biopha.2026.119105_bib24","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/(SICI)1097-0215(19960117)65:2<230::AID-IJC17>3.0.CO;2-H","article-title":"Overlapping phenotypes of multidrug resistance among panels of human cancer-cell lines","volume":"65","author":"Izquierdo","year":"1996","journal-title":"Int. J. Cancer"},{"issue":"5","key":"10.1016\/j.biopha.2026.119105_bib25","doi-asserted-by":"crossref","first-page":"793","DOI":"10.2174\/138161282005140214165212","article-title":"ABC transporters in multidrug resistance and pharmacokinetics, and strategies for drug development","volume":"20","author":"Choi","year":"2014","journal-title":"Curr. Pharm. Des."},{"issue":"7","key":"10.1016\/j.biopha.2026.119105_bib26","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/s41568-018-0005-8","article-title":"Revisiting the role of ABC transporters in multidrug-resistant cancer","volume":"18","author":"Robey","year":"2018","journal-title":"Nat. Rev. Cancer"},{"issue":"11","key":"10.1016\/j.biopha.2026.119105_bib27","doi-asserted-by":"crossref","first-page":"5753","DOI":"10.1021\/cr4006236","article-title":"Targeting the Achilles heel of multidrug-resistant cancer by exploiting the fitness cost of resistance","volume":"114","author":"Szakacs","year":"2014","journal-title":"Chem. Rev."},{"issue":"3","key":"10.1016\/j.biopha.2026.119105_bib28","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrd1984","article-title":"Targeting multidrug resistance in cancer","volume":"5","author":"Szakacs","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"issue":"10","key":"10.1016\/j.biopha.2026.119105_bib29","first-page":"1360","article-title":"Evaluation the interaction of ABC multidrug transporter MDR1 with thymoquinone: substrate or inhibitor? Iran","volume":"23","author":"Keyvani","year":"2020","journal-title":"J. Basic Med. Sci."},{"issue":"12","key":"10.1016\/j.biopha.2026.119105_bib30","doi-asserted-by":"crossref","first-page":"6457","DOI":"10.21873\/anticanres.13859","article-title":"Association of ABC transporter with resistance to FK866, a NAMPT inhibitor, in human colorectal cancer cells","volume":"39","author":"Ogino","year":"2019","journal-title":"Anticancer Res"},{"issue":"3","key":"10.1016\/j.biopha.2026.119105_bib31","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/bph.13376","article-title":"Blood-brain and retinal barriers show dissimilar ABC transporter impacts and concealed effect of P-glycoprotein on a novel verapamil influx carrier","volume":"173","author":"Chapy","year":"2016","journal-title":"Br. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.biopha.2026.119105_bib32","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1021\/acschembio.4c00353","article-title":"Modulation of ABCG2 transporter activity by Ko143 derivatives","volume":"19","author":"Yu","year":"2024","journal-title":"ACS Chem. Biol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119105_bib33","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/andr.13340","article-title":"Inhibition of multidrug resistance proteins by MK571 restored the erectile function in obese mice through cGMP accumulation","volume":"11","author":"de Oliveira","year":"2023","journal-title":"Andrology"},{"issue":"9","key":"10.1016\/j.biopha.2026.119105_bib34","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S1357-4310(99)01540-3","article-title":"The Oncostatin M signalling pathway: reversing the neoplastic phenotype?","volume":"5","author":"Grant","year":"1999","journal-title":"Mol. Med Today"},{"issue":"24","key":"10.1016\/j.biopha.2026.119105_bib35","doi-asserted-by":"crossref","first-page":"9739","DOI":"10.1073\/pnas.83.24.9739","article-title":"Oncostatin M: a growth regulator produced by differentiated histiocytic lymphoma cells","volume":"83","author":"Zarling","year":"1986","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.biopha.2026.119105_bib36","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.bcp.2011.04.017","article-title":"Regulation of drug transporter expression by Oncostatin M in human hepatocytes","volume":"82","author":"Le Vee","year":"2011","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119105_bib37","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/hep.20086","article-title":"Hepatocyte proliferation and tissue remodeling is impaired after liver injury in Oncostatin M receptor knockout mice","volume":"39","author":"Nakamura","year":"2004","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.biopha.2026.119105_bib38","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1189\/jlb.0410217","article-title":"gp130 at the nexus of inflammation, autoimmunity, and cancer","volume":"88","author":"Silver","year":"2010","journal-title":"J. Leukoc. Biol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119105_bib39","first-page":"210","article-title":"gp130 and the IL-6 family of cytokines: signaling mechanisms and thrombopoietic activities","volume":"35","author":"Nakashima","year":"1998","journal-title":"Semin Hematol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222600137X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222600137X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T14:45:49Z","timestamp":1781880349000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333222600137X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":39,"alternative-id":["S075333222600137X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119105","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oncostatin M-induced ABCC2 suppression sensitizes hepatocellular carcinoma cells to chemotherapeutics","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119105","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119105"}}